This inventor holds 5 USPTO granted patents. Top assignees: The University of Toledo, Washington State University. Active years: 2020-2024.
Company Filing History:
5 out of 368 
3 out of 471 
Years Active: 2020-2024
Title: Kenneth Hensley: Innovator in Autophagy-Related Therapies
Introduction
Kenneth Hensley is a notable inventor based in Toledo, OH (US). He has made significant contributions to the field of therapeutic compositions, particularly those related to autophagy-related pathologies. With a total of 5 patents to his name, Hensley's work is paving the way for advancements in medical treatments.
Latest Patents
Hensley's latest patents include compositions that are useful in the therapy of autophagy-related pathologies. These patents describe methods of making and using lanthionine ketimine phosphonate (LK-P), lanthionine ketimine ester phosphonate (LKE-P), and other derivatives. His work also encompasses lanthionine ketimine derivatives that feature a tert-enamide moiety at the 2-position (NVP-LKE). These innovative compositions and methods are aimed at improving treatment options for various health conditions.
Career Highlights
Throughout his career, Kenneth Hensley has been associated with reputable institutions such as the University of Toledo and Washington State University. His research and inventions have garnered attention in the scientific community, contributing to the advancement of therapeutic techniques.
Collaborations
Hensley has collaborated with notable colleagues, including Travis Denton and Bruce Levison. These partnerships have played a crucial role in the development of his innovative therapies.
Conclusion
Kenneth Hensley's contributions to the field of autophagy-related therapies highlight his role as a significant inventor. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.